- Efficacy and toxicity of concomitant cisplatin with external beam ...🔍
- The outcomes of concomitant hypofractionated simultaneous ...🔍
- Feasibility of Concomitant Chemoradiotherapy in Daily Practice for ...🔍
- Efficacy and toxicity of nimotuzumab combined with radiotherapy in ...🔍
- Evaluation of the efficacy of prophylactic extended field irradiation in ...🔍
- A phase II study of cisplatin with intravenous and oral vinorelbine as ...🔍
- Efficacy and Safety of Concomitant Chemoradiotherapy ...🔍
- Local control and toxicity after stereotactic radiotherapy in brain ...🔍
The toxicity and efficacy of concomitant chemoradiotherapy in ...
Efficacy and toxicity of concomitant cisplatin with external beam ...
Lanciano R. Management of cervical cancer by radiotherapy. in: Luesley D.M. Barrasso R. Cancer and pre-cancer of the cervix. Chapman & Hall Medical, London ...
The outcomes of concomitant hypofractionated simultaneous ...
Studies with a larger. Page 2. 21 −. © Oncology and Radiotherapy 15 (12) 2021: 20-29 single fractionated dose showed increased efficacy, as ...
Feasibility of Concomitant Chemoradiotherapy in Daily Practice for ...
Conclusion: Although concomitant chemoradiotherapy is the standard-of-care in patients with stage IIIA/B NSCLC ineligible for surgery, the majority (80%) of the ...
Efficacy and toxicity of nimotuzumab combined with radiotherapy in ...
There was one case of treatment‑related mortality due to RP during the study. One patient developed a rash on the forearm. No hematological, ...
Evaluation of the efficacy of prophylactic extended field irradiation in ...
... Concomitant chemoradiotherapy, Acute toxicity. © The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons ...
A phase II study of cisplatin with intravenous and oral vinorelbine as ...
Concomitant platinum-based chemotherapy and radiotherapy (CT-RT) is the recommended treatment for unresectable locally advanced stage III ...
Efficacy and Safety of Concomitant Chemoradiotherapy ... - CiteSeerX
Background: Chemoradiation (CRT) using cisplatin-based regimens has become the standard of care in the treatment of squamous cell head and neck cancers (SCHNC).
Local control and toxicity after stereotactic radiotherapy in brain ...
Highlights•Systemic treatment combined with radiotherapy provides better local control. ... Toxicity was not increased in patients using immunotherapy or targeted ...
Efficacy and toxicity of three concurrent chemoradiotherapy ...
Platinum was the most widely used drug for NPC in induction, concomitant and adjuvant chemotherapy settings. The first-generation platinum, ...
Efficacy and Low Toxicity of Normo-Fractionated Re-Irradiation with ...
Treatment toxicity analysis showed higher rates of hematological adverse events for patients treated with combination chemotherapy, especially higher rates of ...
a pooled analysis based on individual patient data of CALGB ...
Adding induction chemotherapy did not achieve a superior efficacy but increased the burden from toxicity. Accordingly, we retrospectively investigated the ...
Weighted Toxicity Score: Confirmation of a Simple Metric to ...
Chemoimmunotherapy combinations consistently outperformed the chemotherapy arms on both metrics of efficacy (median OS and median PFS). Lung ...
Tolerability, Efficacy and Feasibility of Concurrent Gemcitabine and ...
The further evaluation also demonstrated that the neoadjuvant strategy is at least as efficient as standard concomitant chemoradiotherapy involving cisplatin. A ...
Real world efficacy and toxicity of consolidation durvalumab ...
Consolidation durvalumab following platinum-based chemoradiotherapy (CRT) significantly improved overall survival for patients with unresectable stage III ...
Outcomes, toxicity profiles, and prognostic factors of unresectable ...
The optimized treatment for locally advanced and unresectable lesions is mainly based on radiotherapy associated with chemotherapy (cisplatin 100mg/m²), however ...
154 Concomitant radiochemotherapy and intracavitary hyperthermia ...
Results Toxicity according EORTC/RTOG scale was assessed: Early toxicity were not observed. The late toxicity from bladder I° and II° in 4 (8%) patients, IV° in ...
Boosting the efficacy and reducing the toxicity of the chemotherapy ...
Naama Kanarek, a postdoctoral researcher in the lab of Whitehead Member David Sabatini, explains how new genetic tools are allowing insights into the ...
Concomitant intensive chemoradiotherapy induction in non ... - Nature
In our protocol, after 24 patients we intensified the dose of induction chemotherapy as described, and no difference in local response was found ...
Efficacy of concomitant and adjuvant temozolomide in glioblastoma ...
The introduction of TMZ before, during and after radiotherapy for newly diagnosed glioblastoma multiforme gives clinically and statistically significant ...
Phase I Study of Induction Chemotherapy and Concomitant ...
Compared with induction chemother- apy with carboplatin-paclitaxel in CALGB 39801,6 with a response rate was 31%, the efficacy of the triplet induction regimen ...